- Meeting abstract
- Open Access
The effect of local application of tranexamic acid to reduce blood loss after off pump coronary artery bypass grafting (CABG)
© Hossain and Moinuddin 2015
- Published: 16 December 2015
- Coronary Artery Bypass Grafting
- Tranexamic Acid
- Reduce Blood Loss
- Chest Tube Drainage
- Postoperative Blood Loss
After off-pump CABG surgery, bleeding and requirement of blood transfusion are the most common problems. Systemic use of antifibrinolytic reduces the postoperative blood loss. We have evaluated the effect of the topical use of tranexamic acid in the pericardial cavity on postoperative bleeding following open heart surgery.
To evaluate the effect of local application of tranexamic acid to reduce blood loss after off pump coronary artery bypass grafting (CABG).
Total 150 patients were enrolled in this double-blind, randomized, placebo-controlled, prospective clinical trial scheduled for primary isolated off pump coronary artery bypass grafting, divided in 2 groups (each group consisting of 100 patients). Patients with coagulopathies, renal failure, re-do surgery, or recent anti-platelet treatment were excluded. Tranexamic acid (TA) group (75 patients) received 1 gram of TA diluted in 100 ml normal saline. Placebo group (75 patients) received 100 ml of normal saline only. The solution was purred in the pericardial and mediastinal cavities before sternal closure. Postoperative blood loss, need for transfusion of blood products and the rate of re-sternotomy for bleeding were documented.
Both groups were comparable in their baseline demographic and surgical characteristics. In comparison with the placebo group, the patients receiving tranexamic acid had a significantly less chest tube drainage During the first 24 hours post-operatively up. In the tranexamic acid group (366 ± 158 mL) compared to the placebo group (580 ± 265 mL, p < 0.0001). There were no differences in mortality, morbidity between the 2 groups. More blood transfusions were administered to Placebo group patients (4.8 ± 1.61 units) as compared to Group I patients (2.46 ± 1.2 units, p < 0.0001). Re-exploration for excessive surgical bleeding in two patient in TA group, no difference was found in morbidity or mortality between both groups.
Topical application of tranexamic acid in patients undergoing primary coronary artery bypass grafting led to a significant reduction in postoperative mediastinal bleeding and requirement blood transfusion without adding extra risk to the patient.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.